Warnings
No Logo
检测到 扑热息痛 6mg, 西地那非 86mg。 地点：Barcelona, 西班牙。 日期：2022-01-18。 来源：energycontrol.org。
Detected Substances
- Paracetamol 6mg
- Sildenafil 86mg
Expected vs Detected
No expected substance was recorded for this sample.
Detected result: Paracetamol 6mg, Sildenafil 86mg
Sample Details
- Weight: 350
Testing Context
- Location: Barcelona, 西班牙
- Date tested: 2022-01-18
- Source: energycontrol.org
Harm Reduction
- Similar-looking pills can contain different substances or strengths.
- Use drug checking services when available.
- Start low and avoid assuming a logo identifies the contents.
SampleDNA Beta
687 条相关警告 · 了解常见杂质的更多信息。
- Paracetamol6mg
- Sildenafil86mg
相关样本和组合
No Logo 徽标
在相关药物检测结果中出现相同的徽标。
Paracetamol
在相关药物检测结果中共同检测到。
Acetylcodeine + Caffeine + Heroin + Noscapine + Papaverine + Paracetamol + Unknown
在相关药物检测结果中共同检测到。
- Heroin + Caffeine + Paracetamol + Noscapine + Acetylcodeine + Papaverine + Unknown
- Heroin + Caffeine + Paracetamol + Noscapine + Acetylcodeine + Papaverine + Unknown
- Heroin + Caffeine + Paracetamol + Noscapine + Acetylcodeine + Papaverine + Unknown
- Heroin + Caffeine + Paracetamol + Noscapine + Acetylcodeine + Papaverine + Unknown
- Heroin + Noscapine + Paracetamol + Caffeine + Acetylcodeine + Papaverine + Unknown
- Heroin + Paracetamol + Caffeine + Noscapine + Acetylcodeine + Papaverine + Unknown
6-MAM + Caffeine + Diacetylmorphine + Noscapine + Papaverine + Paracetamol + Unknown
在相关药物检测结果中共同检测到。
- Diacetylmorphine + 6-MAM + Papaverine + Noscapine + Paracetamol + Caffeine + Unknown
- 6-MAM + Diacetylmorphine + Papaverine + Noscapine + Caffeine + Paracetamol + Unknown
- Diacetylmorphine + 6-MAM + Caffeine + Papaverine + Noscapine + Paracetamol + Unknown
- Diacetylmorphine + 6-MAM + Papaverine + Noscapine + Caffeine + Paracetamol + Unknown
- Diacetylmorphine + Caffeine + 6-MAM + Noscapine + Papaverine + Paracetamol + Unknown
- Diacetylmorphine + 6-MAM + Noscapine + Papaverine + Caffeine + Paracetamol + Unknown
Links
This static page is intended as the readable export baseline for crawler and low-capability delivery.
